Keel Point, LLC Bristol Myers Squibb CO Transaction History

Keel Point, LLC

$1.19 Billion
Q3 2024

A detailed history of Keel Point, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keel Point, LLC holds 5,006 shares of BMY stock, worth $289,146. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,006

Previous 4,902 2.12%

Holding current value

$289,146

Previous $203,000 27.59%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $4,124 - $5,382	104 Added 2.12%	5,006 $259,000
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $23,143 - $30,469	575 Added 13.29%	4,902 $203,000
Q1 2024 Apr 16, 2024	BUY	$47.98 - $54.4 $207,609 - $235,388	4,327 New	4,327 $234,000
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $20,087 - $22,461	-347 Reduced 8.03%	3,972 $230,000
Q2 2023 Jul 12, 2023	BUY	$63.71 - $70.74 $54,217 - $60,199	851 Added 24.54%	4,319 $276,000
Q1 2023 Apr 03, 2023	SELL	$65.71 - $74.53 $6,833 - $7,751	-104 Reduced 2.91%	3,468 $240,000
Q4 2022 Jan 17, 2023	BUY	$68.48 - $81.09 $50,880 - $60,249	743 Added 26.26%	3,572 $0
Q3 2022 Oct 05, 2022	BUY	$0.13 - $76.84 $2 - $1,767	23 Added 0.82%	2,829 $201,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $19,099 - $21,034	-263 Reduced 8.57%	2,806 $210,000
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $188,682 - $226,246	3,069 New	3,069 $224,000
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $15,265 - $17,881	-258 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $15,972 - $17,394	258 New	258 $558,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $286,737 - $341,899	-6,355 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $21,942 - $28,453	-450 Reduced 6.61%	6,355 $330,000
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $26,491 - $29,880	480 Added 7.59%	6,805 $422,000
Q2 2017 Aug 15, 2017	BUY	N/A	6,325	6,325 $352,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account